Clonal hematopoiesis and vascular disease

Area of Science:

• Hematology
• Immunology
• Cardiovascular Science

Background:

• Somatic mutations in hematopoietic stem cells (HSCs) are frequent with aging, leading to clonal expansion known as clonal hematopoiesis.
• Clonal hematopoiesis is linked to increased blood cancer risk, chronic inflammatory diseases, and atherogenesis.
• Immune cells are identified as effector cells, prompting research into their role in chronic inflammatory conditions like rheumatologic disease.

Purpose of the Study:

• To summarize current understanding of clonal hematopoiesis.
• To focus on the established role of clonal hematopoiesis in cardiovascular disease and inflammation.
• To explore the potential relationship between clonal hematopoiesis and autoimmune disease.

Main Methods:

• Review of current literature on clonal hematopoiesis.
• Analysis of the role of immune cells in clonal hematopoiesis-related inflammation.
• Identification of knowledge gaps regarding clonal hematopoiesis and autoimmune disorders.

Main Results:

• Clonal hematopoiesis of indeterminate potential (CHIP) involves mutations in cancer-associated genes, leading to clonal expansion without overt malignancy.
• CHIP is causally linked to atherosclerotic cardiovascular disease and inflammation.
• The potential contribution of CHIP to autoimmune disease pathogenesis is an area for future research.

Conclusions:

• Clonal hematopoiesis is a significant factor in cardiovascular disease and inflammation.
• Further research is needed to elucidate the role of clonal hematopoiesis in autoimmune diseases.
• Understanding the interplay between HSCs, immune function, and chronic inflammatory conditions is crucial.